Background
==========

The host response to infection is central to the effective control and ultimate clearance of invading pathogens or removal of infected cells. Infection of host with a viral pathogen marks the onset of changes in the host cell\'s microenvironment. Such changes in host gene expression could be a cellular antivirus response, a virus induced response that facilitate its own replication and spread or a non-specific response that neither promotes nor prevents virus infection. This alteration of expression of many cellular genes can be identified using cDNA microarray \[[@B1]\].

Defining the transcriptional regulation of host genes on virus infection can be used as a tool to obtain an elaborate insight into mechanisms of host-virus interactions and to unravel the molecular basis of disease pathogenesis. Viruses from several families can infect neurons in the CNS (Central Nervous System) and the study of gene expression changes in the CNS during virus infection can lead to identification of new genes whose function is essential either for the promotion or prevention of virus infection \[[@B2],[@B3]\].

Japanese Encephalitis is one of the most dreaded mosquito borne encephalitis virus causing acute encephalitis in humans. Among the medically important flaviviruses, JEV infection has the highest mortality rate of 30-50% \[[@B4],[@B5]\] and remains as a major public health problem in several parts of Asia. The main concern is the constant spreading of JE to new geographical areas \[[@B6]\]. Better understanding of JEV pathogenesis is required to identify risk factors for progression of disease and viral persistence, which may help in the development of differential diagnostics and new therapeutic interventions.

In a previous study, employing cDNA microarray, we identified various antiviral genes along with the innate immune response related chemokine expression at very early phase of infection in mouse neuronal cells \[[@B7]\]. However, there is no information available on genome wide host gene expression changes induced by JEV in the CNS and in a natural route of infection. There is a requirement to understand the molecular events responsible for disease progression, viral persistence and complex biological processes of host response during the complete course of JEV infection, starting from peripheral route to CNS, neuroinflammation, disease severity and death.

Thus, we employed cDNA microarray for the systematic analysis of global host transcriptional responses in CNS of JEV infected mice. In the recent epidemics, it has been observed that the mortality rate in JEV infected patients is higher in 1-5 years of age group with immature immune system. So we employed a young mice model to explore the precise molecular events involved in JEV infection of CNS during the disease severity. Subcutaneous challenge of JEV in one-week-old mice provides a natural route of exposure to study molecular mechanism of JEV pathogenesis in CNS. In our earlier report using this animal model we observed a significant regulation of IFN-γ in virus infected mice spleen, which demonstrates a specific but insufficient anti-viral response in the periphery to limit virus spread to brain \[[@B8]\]. Thus this model with immature immune system may provide important information about the role of host response in disease severity. The reproducibility of the infection and diseases symptoms was verified with a significant number of experimental repetitions in newly established animal model and there was no variation in the disease symptoms of the individual animals at any time point of infection and the mortality rate was also 100% at 6 DPI (Day post-infection).

It has already been reported that cerebral cortex is an important site of virus replication, inflammation, injury and is associated with encephalitis in the JEV-infected host \[[@B9],[@B10]\]. Thus we employed brain cerebral cortex for the investigation of transcriptomic profile of host response in JEV infection. Our results thus provide a genome-wide investigation of an animal model of JEV infection and a genomic view of systemic host-virus interactions during infection.

Results
=======

Evaluation of viral load and histopathological analysis in mice CNS after subcutaneous infection with JEV
---------------------------------------------------------------------------------------------------------

Animals showed JE specific symptoms with the progression in severity in a time dependent manner. After subcutaneous inoculation, virus load in brain was evaluated up to 6 DPI by plaque titration assay (Figure [1](#F1){ref-type="fig"}). JEV replicates rapidly in brain with an increase in titre from 2 DPI and reached a maximal viral load at 5 DPI. Subsequently, the viral load remained constant until death at 6 DPI. Figure S1 (Additional file [1](#S1){ref-type="supplementary-material"}) is showing the histopathological analysis of cerebral cortex from mock- and JEV-infected animals with the pathological changes after viral infection. The analysis showed congestion and dilation of blood vessels at 1 DPI. A time dependent increase in mononuclear cell infiltration, prominent peri-vascular cuffing and neuronal degeneration was observed in further time points of infection.

![**Viral load in mouse brain infected with JEV**. Viral load in the cerebral cortex of mice infected with 10^3^PFU of JEV at various days post-infection (DPI). Infectious virus titre was determined using Plaque formation assay on porcine stable (PS) kidney cells. Values are mean ± SE of four replicates each.](1743-422X-8-92-1){#F1}

Host transcription profile after JEV infection
----------------------------------------------

Using whole genome microarray the host transcription profile was studied in mouse brain, the data from mock- and JEV-infected animals were compared in time course study after 1, 2, 4 and 5 DPI. Overall, the largest difference in transcription levels between the mock- and JEV-infected groups was detected at 5 DPI, corresponding to the time of maximum viral load in brain. A total 833 genes were up regulated and 479 genes were down regulated at 5 DPI (Table [1](#T1){ref-type="table"}). The hierarchical clustering also showed significant regulation of a large set of genes at 5 DPI (Figure [2a](#F2){ref-type="fig"} and [2b](#F2){ref-type="fig"}). Gene expression profile at 1 DPI was compared with 5 DPI and 288 genes showed similar regulation in their expression. However, the more similarity in gene expression was observed when 1 DPI was compared with 4 DPI (Figure [3](#F3){ref-type="fig"}). The gene modulation seems to correlate with viral replication and classification of genes reveals critical role of inflammation and immune response in JEV infection (Table [2](#T2){ref-type="table"}).

###### 

Differentially expressed genes in mouse brain at different days after JEV infection.

  -------------------------------------
  Time\                    Up    Down
  \[Day post infection\]         
  ------------------------ ----- ------
  Day 1                    342   384

  Day 2                    381   259

  Day 4                    459   425

  Day 5                    833   479
  -------------------------------------

![**Global gene expression profiles in the brain of BALB/c mice in response to JEV infection**. Genes were sorted using hierarchical clustering, average linkage and Pearson uncentred correlation. Green and red bands represent downregulated or upregulated levels of mRNA expression relative to mock-infected mouse, respectively. (A) Genes upregulated (≥2.0-fold changes) with P ≤ 0.05. (B) Genes downregulated (≤ -2.0-fold change) with P ≤ 0.05.](1743-422X-8-92-2){#F2}

![**Comparison of gene expression at different days of infection**. A Venn diagram depicting the differentially expressed genes (≥2.0-fold change or ≤ -2.0-fold change; P ≤ 0.05) unique or common at (A) 1 DPI versus 2 DPI (B) 1 DPI versus 4 DPI and (C) 1 DPI versus 5 DPI. Left circle corresponds to the 1 DPI while right circle in each figure corresponds to 2, 4 and 5 DPI respectively. Green and red indicates down regulated and up regulated genes respectively.](1743-422X-8-92-3){#F3}

###### 

Representation of statistically significant genes categorised into genetic pathways by the KEGG classification system, in mouse brain after JEV infection.

  KEGG Pathway                                        Number of genes   P-value
  --------------------------------------------------- ----------------- ----------
  Intracellular signaling cascade                     192               1.4E-05
  Negative regulation of biological process           187               0.0002
  Immune response                                     136               1.7E-25
  Cell adhesion                                       132               1.03E-05
  Defense response                                    106               1.2E-09
  Apoptosis                                           77                0.001
  Inflammatory response                               44                1.8E-05
  Chemotaxis                                          39                6.2E-08
  Antigen processing and presentation                 39                4.3E-16
  Integrin-mediated signaling pathway                 26                0.0008
  G-protein-coupled receptor binding                  19                0.0001
  Interleukin binding                                 18                2.1E-05
  Response to virus                                   18                3.1E-05
  Cytokine and chemokine mediated signaling pathway   17                0.0001
  Chemokine activity                                  16                3.3E-05
  Chemokine receptor binding                          16                3.3E-05
  Complement activation                               14                0.0003
  Leukocyte mediated immunity                         11                0.0005
  MHC protein complex                                 10                1.6E-08
  Immunoglobulin mediated immune response             10                0.0004
  Leukocyte chemotaxis                                10                0.001

Expression profile of cell surface molecules in brain after JEV infection
-------------------------------------------------------------------------

The host transcription profile in brain showed the effect of JEV infection on expression of various cellular receptors. Gene ontology analysis of these significantly activated cell surface receptors showed their involvement in immune response, inflammatory response, cell adhesion, defense response, proteolysis, endocytosis and chemokine signaling (Table [3](#T3){ref-type="table"}). The lectin receptors like Clec7a, Clec5a, Clec4e involved in the immune responses showed a high level of expression at 5 DPI along with other receptors involved in immune response like Masp2. Receptors involved in immune response like Cd8a and Cd40 were significantly up-regulated at 5 DPI only except Lgals3bp which has showed significant up regulation at 1 DPI also. The receptor involved in inflammatory response showed high level of expression at 5 DPI like Tlr (Toll-like receptor) 2, Tlr7, Edg3, Tnfrsf1b and Cd14 except sialic acid receptor Siglec1 and Tlr4 which showed significant regulation at 1 DPI also (Table [3](#T3){ref-type="table"}). The receptors of cell adhesion family like Sell, Icam1, Amica1, Vcam1, Itgb2 and Itgam showed high level of expression at 5 DPI. The receptors involved in signal transduction like Gpr84 showed increase in their expression in association with the disease progression. However, receptors like Osmr and Admr were significantly up regulated at 5 DPI except Ccrl2 which was up regulated at 2 DPI. The receptors involved in defense response showed varying levels of expression, like Tlr1 was up regulated throughout the disease course with increase in up regulation at 5 DPI while C180 showed a gradual increase in regulation with significant up regulation at 4 and 5 DPI. Another receptor Clec2 d, involved in defense response was up regulated at 1 DPI and further up regulation was found at 4 and 5 DPI. Interestingly, Tlr3 showed up regulation at all the time points of infection but there was an increase in level of expression at 1 and 4 DPI. However, T cell mediated cytotoxicity receptor Ptprc showed high level of expression at 4 and 5 DPI. Interestingly, receptors involved in cytokine and chemokine signalling like Csf2rb2, Csf2rb1, Ccr5 and Il2rb showed significant up regulation only at 5 DPI except Lilrb3 which was significantly up regulated at 1 DPI also (Table [3](#T3){ref-type="table"}). Various other receptors like Msr1, Fas, Selp, Traf1, Treml4 and Pik3ap1 also showed significant up regulation at 5 DPI.

###### 

Differential expression of cell surface molecules in brain after JEV infection.

  Biological Process                         Gene Symbol   Accession No                   Description                                               Fold change over mock-infected                   
  ------------------------------------------ ------------- ------------------------------ --------------------------------------------------------- -------------------------------- ------- ------- ------
  Immune response                            Clec7a†       [NM_020008](NM_020008)         C-type lectin domain family 7                             0.49                             2.34    1.32    6.34
  Immune response                            Clec5a        [NM_001038604](NM_001038604)   C-type lectin domain family 5                             1.32                             1.85    2.07    5.90
  Protein binding scavenger                  Lgals3bp      [NM_011150](NM_011150)         Lectin, galactoside-binding, soluble, 3 binding protein   4.23                             3.58    3.92    4.90
  Inflammatory response                      Tlr2†         [NM_011905](NM_011905)         Toll-like receptor 2                                      0.87                             1.34    1.40    4.90
  Cell adhesion                              Sell          [NM_011346](NM_011346)         Selectin, lymphocyte                                      -0.96                            -0.55   -0.60   4.85
  Inflammatory response                      Siglec1†      [NM_011426](NM_011426)         Sialic acid binding Ig-like lectin 1                      2.39                             2.80    2.29    4.83
  Immune response                            Clec4e        [NM_019948](NM_019948)         C-type lectin domain family 4                             -0.87                            -0.46   -0.61   4.57
  Signal transduction                        Gpr84         [NM_030720](NM_030720)         G protein-coupled receptor 84                             2.10                             2.66    3.25    4.47
  Endocytosis                                Msr1          [NM_031195](NM_031195)         Macrophage scavenger receptor 1                           -0.94                            -0.56   1.10    4.40
  Defense response                           Tlr3†         [NM_126166](NM_126166)         Toll-like receptor 3                                      3.56                             2.47    5.03    4.27
  T cell mediated cytotoxicity               Ptprc         [NM_011210](NM_011210)         Protein tyrosine phosphatase, receptor                    1.63                             1.78    2.00    4.27
  Signal transduction                        Ccrl2†        [NM_017466](NM_017466)         Chemokine (C-C motif) receptor-like 2                     1.66                             2.50    1.98    4.16
  Cytokine & Chemokine signaling             Lilrb3        [NM_011095](NM_011095)         Leukocyte immunoglobulin-like receptor                    2.06                             1.94    0.65    4.09
  Immune response                            Lgals3        [NM_010705](NM_010705)         Lectin, galactose binding, soluble 3                      1.58                             1.40    1.40    4.00
  Defense response                           Tlr1          [NM_030682](NM_030682)         Toll-like receptor 1                                      2.38                             2.15    2.34    3.92
  Apoptosis                                  Fas           [NM_007987](NM_007987)         Fas (TNF receptor superfamily)                            0.24                             0.79    0.77    3.90
  Antibody-dependent cellular cytotoxicity   Fcgr1         [BC025535](BC025535)           Fc receptor, IgG, high affinity I                         4.23                             1.72    3.05    3.79
  Immune response                            Masp2†        [NM_010767](NM_010767)         Mannan-binding lectin serine peptidase                    1.66                             2.74    3.70    3.75
  ADP-ribosylation                           Plec1         [BC024074](BC024074)           Plectin 1                                                 2.35                             1.15    2.57    3.71
  Inflammatory response                      Tlr4          [NM_021297](NM_021297)         Toll-like receptor 4                                      2.11                             1.96    2.15    3.57
  Cytokine & Chemokine signaling             Csf2rb2       [NM_007781](NM_007781)         Colony stimulating factor 2 receptor                      1.10                             1.08    1.38    3.57
  Inflammatory response                      Selp          [NM_011347](NM_011347)         Selectin, platelet                                        -0.06                            0.54    -0.67   3.57
  Cell adhesion                              Icam1†        [BC008626](BC008626)           Intercellular adhesion molecule                           0.85                             0.85    0.82    3.57
  NC                                         Lgals9        [NM_010708](NM_010708)         Lectin, galactose binding, soluble 9                      2.27                             1.18    2.41    3.54
  Cytokine & Chemokine signaling             Csf2rb1       [AK154286](AK154286)           Colony stimulating factor 2 receptor                      0.57                             1.23    1.43    3.52
  Immune response                            Il18bp        [NM_010531](NM_010531)         Interleukin 18 binding protein                            2.59                             0.90    1.72    3.32
  NC                                         Fcgr4         [NM_144559](NM_144559)         Fc fragment of IgG, low affinity IIIa, receptor           2.06                             1.17    3.39    3.31
  Inflammatory response                      Tlr7†         [NM_133211](NM_133211)         Toll-like receptor 7                                      0.52                             0.97    1.80    3.26
  Cell adhesion                              Amica1        [NM_001005421](NM_001005421)   Adhesion molecule, interacts with CXADR antigen 1         1.08                             0.78    0.72    3.24
  Immune response                            Cd8a          [NM_001081110](NM_001081110)   CD8 antigen, alpha chain                                  -0.97                            -0.55   -0.60   3.15
  Cell adhesion                              Vcam1         [NM_011693](NM_011693)         Vascular cell adhesion molecule 1                         1.06                             0.54    0.83    3.13
  Phagocytosis                               Fcgr2b        [NM_010187](NM_010187)         Fc receptor, IgG, low affinity IIb                        0.19                             0.65    0.17    3.09
  Signal transduction                        Osmr          [NM_011019](NM_011019)         Oncostatin M receptor                                     0.52                             0.36    1.19    2.86
  NC                                         Il21r         [NM_021887](NM_021887)         Interleukin 21 receptor                                   1.63                             1.21    1.04    2.85
  Defense response                           Cd180         [NM_008533](NM_008533)         Lymphocyte antigen 78                                     -1.40                            1.32    2.41    2.85
  Defense response                           Clec2d        [NM_053109](NM_053109)         C-type lectin domain family 2                             2.14                             0.97    2.40    2.83
  NC                                         Lair1         [NM_178611](NM_178611)         Leukocyte-associated Ig-like receptor                     1.01                             1.48    1.27    2.80
  Type IIa hypersensitivity                  Fcer1g        [NM_010185](NM_010185)         Fc receptor, IgE, high affinity I, gamma polypeptide      0.98                             1.21    0.81    2.78
  Signal transduction                        Admr          [NM_007412](NM_007412)         Adrenomedullin receptor                                   1.38                             0.61    0.84    2.71
  Cell adhesion                              Itgb2         [NM_008404](NM_008404)         Integrin beta 2                                           0.60                             1.11    0.58    2.68
  Signal transduction                        Pilra         [NM_153510](NM_153510)         Paired immunoglobin-like type 2                           1.20                             2.17    1.38    2.64
  Apoptosis                                  Traf1         [NM_009421](NM_009421)         Tnf receptor-associated factor 1                          1.12                             0.64    0.62    2.62
  Signal transduction                        Il15ra        [NM_008358](NM_008358)         Interleukin 15 receptor, alpha chain                      1.29                             0.77    1.52    2.60
  Inflammatory response                      Edg3          [NM_010101](NM_010101)         Sphingolipid g-protein-coupled receptor,                  1.66                             1.63    1.71    2.57
  Signal transduction                        Il10ra        [NM_008348](NM_008348)         Interleukin 10 receptor, alpha                            0.72                             1.06    0.89    2.55
  NC                                         Paqr5         [NM_028748](NM_028748)         Progestin and adipoq receptor family member V             1.24                             1.49    2.51    2.47
  NC                                         Treml4        [NM_172623](NM_172623)         Triggering receptor expressed on myeloid cells-like 4     0.33                             0.83    -0.69   2.45
  Cell adhesion                              Itgam         [NM_008401](NM_008401)         Integrin alpha M                                          0.66                             0.71    1.60    2.44
  Proteolysis                                Arts1         [NM_030711](NM_030711)         Type 1 TNF receptor shedding aminopeptidase regulator     1.36                             0.98    1.50    2.40
  Signal transduction                        Pik3ap1       [NM_031376](NM_031376)         Phosphoinositide-3-kinase adaptor protein 1               0.96                             1.25    1.23    2.37
  Inflammatory response                      Tnfrsf1b      [NM_011610](NM_011610)         Tumor necrosis factor receptor superfamily, member 1b     0.56                             0.47    0.39    2.31
  Signal transduction                        Il12rb1       [NM_008353](NM_008353)         Interleukin 12 receptor, beta 1                           1.06                             0.57    0.35    2.25
  Chemotaxis                                 Ccr5          [NM_009917](NM_009917)         Chemokine (C-C motif) receptor 5                          1.18                             1.66    1.40    2.22
  NC                                         Il2rg         [NM_013563](NM_013563)         Interleukin 2 receptor, gamma chain                       1.28                             0.43    -0.28   2.19
  Inflammatory response                      Cd14          [NM_009841](NM_009841)         Cd14 antigen                                              0.15                             0.78    0.14    2.12
  Proteolysis                                Lnpep         [NM_172827](NM_172827)         Leucyl/cystinyl aminopeptidase                            0.78                             1.01    0.67    2.10
  Immune response                            Cd40          [NM_170701](NM_170701)         CD40 antigen                                              0.67                             0.24    0.35    2.10
  Cytokine & Chemokine signaling             Il2rb         [NM_008368](NM_008368)         Interleukin 2 receptor, beta chain                        0.17                             0.63    0.09    2.10

† Gene regulation was validated by Real time qRT-PCR.

Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.

NC Not classified

Differential expression of genes in brain after JEV infection
-------------------------------------------------------------

Members of a large subset of genes involved in immune response and inflammation were differentially expressed in brain of JEV-infected animals. Within this group of immune response, expression of Oligoadenylate synthetase family members were significantly upregulated during the disease course except Oas3 which showed gradual increase in its expression from 1 to 5 DPI. The genes belonging to GTPase family also showed very high level of expression during the disease course. Other genes involved in immune response which were up regulated in all time point of infection were Mpa 21, Mx2, Mx1 Phf11, Tgtp, B2 m and Tap1 (Table S1, Additional file [2](#S2){ref-type="supplementary-material"}). The inflammatory response genes include a large number of CXC/CC chemokines family genes (Table S2, Additional file [3](#S3){ref-type="supplementary-material"}). Cxcl10, Ccl12, Cxcl9, Cxcl11, Cxcl13 and Tnf-α showed up regulation at 1 DPI with decline at 2 DPI and further up regulation up to 5 DPI. Ptx3, Ccl3, Spp1, Ccl9, Mefv and Ccl8 showed significant up-regulation at 5 DPI only. The inflammatory genes like Il1β and Il1α showed up regulation from 4 DPI onwards while Il6 was significantly up regulated at 5 DPI only. Other important cluster of genes, which are involved in defense response (Table S3, Additional file [4](#S4){ref-type="supplementary-material"}), anti-viral response of IFN pathway (Table S4, Additional file [5](#S5){ref-type="supplementary-material"}) and genes involved in proteolysis (Table S5, Additional file [6](#S6){ref-type="supplementary-material"}), also showed significant regulation of expression at early or acute phase of disease. The genes, which showed significant down-regulation during the disease course, are involved in cell cycle, endocytosis, leukotriene metabolic response, signal transduction, transcription, cell adhesion and apoptosis (Table [4](#T4){ref-type="table"}).

###### 

Down regulated genes expressed in brain after JEV infection.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Biological process              Gene Symbol   Accession No             Description                                      Fold change over mock-infected                   
  ------------------------------- ------------- ------------------------ ------------------------------------------------ -------------------------------- ------- ------- -------
  Defense response                H2-Q1         [U96752](U96752)         Major histocompability complex Q1b               -1.56                            -2.45   -4.46   -4.35

  Endopeptidase\                  Pbp2          [NM_029595](NM_029595)   Phosphatidylethanolamine binding protein 2       -2.67                            -4.40   -1.91   -4.28
  Inhibitor                                                                                                                                                                

  Cell cycle                      Bmpr2         [NM_007561](NM_007561)   Bone morphogenic protein receptor                -3.94                            -4.10   -3.91   -4.02

  Oxidative stress                Epx           [NM_007946](NM_007946)   Eosinophil peroxidase                            -1.05                            1.05    -1.81   -3.75

  Vasoconstriction                Avp           [NM_009732](NM_009732)   Arginine vasopressin                             -3.09                            3.04    -2.71   -3.57

  T cell mediated cytotoxicity    Ptprc         [AK088215](AK088215)     Protein tyrosine phosphatase, receptor type, C   -0.58                            -0.55   -0.62   -3.35

  Inflammatory response           Ccl24         [NM_019577](NM_019577)   Chemokine (C-C motif) ligand 24                  -1.83                            0.39    -0.08   -3.13

  Leukotriene metabolic process   Ltc4          [NM_008521](NM_008521)   Mus musculus leukotriene C4 synthase             -0.30                            0.37    -0.10   -3.01

  Transcription                   Rorb          [AK044421](AK044421)     RAR-related orphan receptor beta                 0.88                             0.91    0.83    -2.91

  Endocytosis                     Mrc1          [NM_008625](NM_008625)   Mannose receptor, C type 1                       -1.34                            -0.42   -1.41   -2.81

  Signal transduction             Calcr         [NM_007588](NM_007588)   Calcitonin receptor                              -3.72                            0.03    -2.71   -2.80

  Leukotriene metabolic process   Alox12        [NM_007440](NM_007440)   Arachidonate 12-lipoxygenase                     -0.73                            0.35    -0.10   -2.72

  NC                              Msr2          [NM_030707](NM_030707)   Macrophage scavenger receptor 2                  0.29                             0.33    0.44    -2.59

  Transport                       Trpa1         [NM_177781](NM_177781)   Transient receptor potential cation channel      0.11                             -2.00   -0.19   -2.52

  Microtubule-based process       Kif1b         [NM_207682](NM_207682)   Kinesin family member 1B                         -0.92                            -1.69   -2.30   -2.48

  Immune response                 Cxcl4         [NM_019932](NM_019932)   Chemokine (C-X-C motif) ligand 4                 -0.61                            0.06    -0.52   -2.33

  Translation                     Eif2s3x       [NM_012010](NM_012010)   Eukaryotic translation initiation factor         -0.28                            -2.47   -2.29   -2.27

  Transcription                   Zfp101        [NM_009542](NM_009542)   Zinc finger protein 101                          -0.48                            -0.36   -2.10   -2.20

  Transcription                   Irx6          [NM_022428](NM_022428)   Iroquois related homeobox 6                      -1.12                            -0.58   -1.20   -2.19

  Prostaglandin biosynthesis      Ptgis         [NM_008968](NM_008968)   Prostaglandin I2                                 -0.67                            -0.46   -1.19   -2.19

  MAPK activity                   Prok2         [NM_015768](NM_015768)   Prokineticin 2                                   -1.67                            -0.53   -1.76   -2.13

  Cell adhesion                   Pcdh12        [NM_017378](NM_017378)   Protocadherin 12                                 -0.17                            -0.27   -0.68   -2.10

  Apoptosis                       Ngfr          [NM_033217](NM_033217)   Nerve growth factor receptor                     -1.74                            0.32    -1.73   -2.00
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NC Not classified

Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.

Validation of microarray data by real-time qRT-PCR analysis
-----------------------------------------------------------

To validate the differential gene expression profiles obtained by microarray analysis, expression of various receptors involved in immune response (Clec7a, Masp2), inflammatory response (Tlr2, Siglec1, Tlr7, and Ifnβ1), signal transduction (Ccrl2), cell adhesion (Icam1) and defense response (Tlr3) were examined by qRT-PCR. These genes were chosen on the basis of their significant regulation at early phase of infection or at disease severity phase. The data demonstrate that the overall results of qRT-PCR were consistent with those of the microarray analysis. Although several fold differences was observed between these two types of analysis because of intrinsic differences between the techniques, the RT-PCR results reveal the same relative regulation of transcription as the microarray data, and confirm that expression of the selected genes was significantly increased in response to infection with JEV (Figure [4](#F4){ref-type="fig"}).

![**Validation of Microarray data of selected genes by qReal-Time RT-PCR**. The mRNA expression levels of various genes were determined to validate the expression data of microarray analysis. The microarray and Real-Time PCR data is plotted in graph for Ccrl2, Ifnβ1, Clec7a, Icam1, Tlr2, Tlr3, Tlr7, Siglec and Masp2 respectively. Gapdh was used as housekeeping gene. The values are Mean ± SE of three biological replicates without pooling RNA. \*Significantly different from control (mock-infected) mouse at p \< 0. 05 by Dunnet\'s test.](1743-422X-8-92-4){#F4}

Discussion
==========

The clinical outcome of a viral infection is largely dependent on the balance between host response and viral replication rates. The interaction of the virus with cell and evasion of the host immune response is crucial to the development of disease in a susceptible host. Japanese encephalitis (JE) is, at present, the single most important cause of viral encephalitis in Asia. In addition to causing acute illness with a high mortality rate, the disease may leave survivors with major mental and physical disabilities. Despite the fact that Japanese encephalitis is a major disease affecting the tropical world, little is known of its pathogenesis due, partly, to the lack of a suitable animal model and the complex cell interactions in infected individuals. Understanding the events that occur within the central nervous system after viral exposure is necessary if effective therapeutic interventions against viral encephalitis are to be developed.

The current investigation shows global transcription profile in the brain of JEV-infected animal in a natural route of exposure. In this study, after subcutaneous infection, animals started showing JE specific symptoms from 3-day post-infection. The tremendous increase in viral load was observed from 4 DPI in this animal model, which may be because of the completion of virus dissemination and release from brain cells. In addition to this, another mechanism behind this robust increase in viral load may be the increase in viral spread through a haematogenous route via endothelium \[[@B9]\], because at this time point of infection there was an increase in BBB permeability also. However, the detailed study is required to explore the possible mechanism of JEV entry in to the CNS. The greatest difference in the gene expression was observed when the viral load peaked in the brain. However, viral titre remains constant after 5 day until time to death; this confirms the role of host response in the severity of disease rather than virus itself. As reported earlier the pooled RNA samples were used for microarray analysis to reduce the effects of biological variation and to easily find the substantive differences \[[@B11]\]. Genes that were differentially expressed during infection can potentially provide insights into the complex regulatory phenomena in response to JEV infection.

The global transcription profile of the mouse brain infected with JEV revealed the activation of a variety of antiviral host defenses early after infection: activation of innate immune responses, protein processing, interferons and interferon-stimulated genes, complement system, activation of natural killer cells, macrophages and leukocyte infiltration into brain. These indicated the induction of an important local inflammatory response by the host after the infection of CNS. The major set of genes/pathways with increased expression observed in present study with JEV are similar to those reported for other neuroinvasive viruses like West Nile virus (WNV). These results suggest that some pathways are commonly activated during neurotropic viral infection of the CNS, and the gene products like Ifn-γ, Cxcl10/IP-10 etc. involved in protective roles at early phase of infection may also contribute to the pathogenesis of the disease at later stage \[[@B2],[@B12]\].

In Flaviviral encephalitis both macrophage and T-cell infiltration appear to play an important role in the virus entry to CNS \[[@B13]\]. The extravasations of these inflammatory cells and generation of host response may require the activation of different mediators involving, respectively, selectins and their ligands, chemokines and chemokine receptors, proinflammatory cytokines, integrins and cell adhesion molecules (CAMs) and matrix metalloproteinases (MMPs).

Chemokines are now recognized as critical regulators of leukocyte trafficking into the CNS. Numerous studies have revealed that resident cell populations of the CNS are able to synthesize and secrete a variety of chemokines. Astrocytes and microglia are the primary source of chemokines following infection with a wide range of neurotropic viruses. Neurons are also capable of secreting chemokines during JEV and WNV infection \[[@B7],[@B14]\]. The early increased expression of cytokine Tnf-α and T-cell activation chemokines, such as Cxcl10/IP-10, Cxcl11/I-TAC, and Cxcl9/Mig-1 suggests their role in the infiltration of leucocytes at an early phase of host response to highly neuroinvasive JEV infection. These chemokines were also up regulated in the brain of animals infected with highly neuroinvasive strains of WNV \[[@B12]\]. Various reports suggest that the interferon and interferon-regulated genes are playing important role in the activation of leukocytes and their infiltration to CNS. In this study, the earliest consistent transcriptional response was an increase in transcript cluster of Ifn-associated genes. This cluster includes Ifn-α, Ifn-β, and Ifn-γ regulated genes. These genes were also found to be involved in the pathogenesis of West Nile virus encephalitis \[[@B15],[@B16]\].

Interestingly, chemokines which are responsible for infiltration of monocytes and macrophage like Ccl5/RANTES and Ccl4/MIP-1β showed increased expression at an acute phase of infection and increases the infiltration of monocyte and macrophages. At this phase of infection before severity of disease, there was an increase in expression of various proinflammatory mediators also like Tnf-α, Il1α, Il1β, Il-12 and Ccl2/MIP-1α along with chemoattractants. These immune mediators may be exacerbating the infiltration of inflammatory cells by increasing the expression of various integrins, cell adhesion molecules, selectins and increased blood-brain barrier permeability. A study with neural stem/progenitor cells infected with JEV also suggested the possible role of these cytokines in the cellular infiltration \[[@B17]\]. Thus, according to the present data it can be hypothesized that the uncontrolled expression of these mediators may be detrimental leading to the disease severity.

Cell-cell adhesion mediated by various genes is critical for interaction of lymphocytes and antigen presenting cells with endothelium and recruitment to the inflammation site. Recent report suggests that Icam1 plays an important role in WNV neuroinvasion and this is also involved in the blood-brain barrier permeability and the progression of neuroinflammation \[[@B18]-[@B20]\]. The combination of IFN-γ with TNF-α or IL-1 can strikingly up regulate the expression of these adhesion molecules \[[@B21]\] and our results also confirm the similar induction of these genes. Though adhesion molecules showed important role in neuroinflammation, a more thorough understanding will help to develop effective anti-inflammation strategies. The reports also suggested the importance of integrins in virus entry and a prominent endothelial cell receptor was also identified as the functional receptor for WNV and JEV in vertebrate cells \[[@B22]\].

Toll-like receptors signal transduction leads to the expression of several proteins that have important roles in the inflammation and immune response to virus. Recent report suggests that Tlr3 is involved in the WNV replication in brain and induction of neuronal injury, may be through inflammation induced cell death in the brain \[[@B23]\]. The present data also showed the increased expression of Tlr3 along with TNF-α at an early phase of JEV infection and it may be involved in virus entry and resultant encephalitis. Studies showed that the induction of Tlr2-mediated cytokine response in the brain contributes to the death of the animal \[[@B24]\]. Tlr2 and Tlr3 cooperation leads to the expression of the macrophage chemoattractants Ccl2 and Ccl5 \[[@B25]\], which may be the case in JEV infection also. Other receptors like Tlr1, Tlr4 and Tlr7 are known to be involved in the exacerbation of virus-induced inflammation and defense response \[[@B26],[@B27]\]. The TLR mediated pathway has been supported with various other important signaling receptors like Lilrb3, Ptprc \[[@B28],[@B29]\]. The transcription profile of these receptors during disease course suggest a cumulative effect of these genes in JEV pathogenesis.

The innate immune response of multicellular organisms is initiated by the binding of soluble and membrane-bound host molecules including lectins to the surface of pathogenic organism. These pattern recognition receptors (PRRs) are required for signal transduction during host response. Lectin receptors like dendritic cell receptor Clec7a, Clec4e are playing important role in the activation of macrophage and innate immune response \[[@B30],[@B31]\]. Recent reports suggest the critical role of macrophage receptor Clec5a in dengue and Japanese encephalitis severity \[[@B8],[@B32]\]. Other macrophage receptors like Masp2 and Siglec1 plays important role in inflammation \[[@B33],[@B34]\]. Taken together, it can be hypothesized that, the JEV activates signal transduction through these receptors, exacerbates the inflammation, and disease severity. These are the newly explored pattern-recognizing C-type lectin receptors on dendritic cells and macrophages and targeting these molecules may provide improved therapeutic options.

The data also presents an interesting set of genes in JEV pathogenesis. These are the caspases, which are not only playing an essential role during apoptotic cell death, but a subfamily of them\--the inflammatory caspase, are associated with immune responses to microbial pathogens \[[@B35]\]. These include caspase-1, 4, 5, 11 and 12. Activation of inflammatory caspases, such as caspase-1 and caspase-5, occurs upon assembly of an intracellular complex, designated the inflammasome \[[@B36]\]. The activation of various pattern recognition receptors like Tlr, C-type lectins and up regulation of Casapse-1, Caspase-4, Pycard, Cathepsin, Il1β and Il18bp indicates the possible generation of inflammasomes during JEV infection. The critical role of Cryopyrin/Nalp3 inflammasomes in case of virus infection has already been discussed \[[@B37]\]. These inflammasomes may be playing important role in JEV pathogenesis and further research is required to identify the role of these inflammasomes in JEV infection.

The present study also provides various important mediators of host anti-viral response at an early phase of infection, those with increased expression included Mx1 and Mx2 (myxovirus resistance 1 and 2), antiviral GTPases, as well as various members of the Oas family, Guanylate nucleotide binding proteins and TRIM protein family. Oas has shown involvement in west-nile virus infection also \[[@B38]\]. Some of these genes like, Oasl2, Oas1a, Oasl1, G1p2, Ifit3 and Iigp2 showed significant regulation at an early phase of infection and these results were consistent with our earlier report on host response in neuronal cell infected with JEV \[[@B7]\]. The significant regulation of these genes along with Trim proteins like Trim 30, 25 and Trim 34 was also observed in the brain of animals infected with highly neuroinvasive strains of WNV \[[@B12]\]. The genes of complement system like C1r, C2, C3, and C4b are known to recognize pathogen-associated molecular patterns (PAMPs) and their involvement in WNV infection is also reported recently \[[@B39]\]. Various hematopoietic cell surface molecules had increased expression, including some Ly6 (lymphocyte) antigens, a group of molecules that are involved in signal transduction and cell activation \[[@B40]\].

These data illustrate that the activation of various PRRs, provides a first line of defense by inducing interferons, proinflammatory cytokines and chemokines \[[@B41],[@B42]\]. These mediators can promote tissue damage if not dampened in a timely manner, such as the increased leukocytic infiltration, which has aggravated the CNS inflammation and causes fatal encephalomyelitis during JEV infection. Recent studies also supported this notion of immunopathogenesis in JEV infection \[[@B43],[@B44]\]. The role of chemokines can not be ignored in this neuroinflammation as they are critical mediators of neuropathology during JEV infection either by attracting pathogenic inflammatory cells or directly mediating neurotoxicity and cell death. The involvement of this aggravated inflammation in disease severity has already been studied with other viral diseases \[[@B45]-[@B47]\].

Conclusion
==========

In conclusion, there is clear evidence for an immunopathological mechanism in the pathogenesis of Japanese encephalitis in mice and may be of use in determining a role for anti-inflammatory agents in the disease management. One of the most interesting aspects of our results is the information on various receptors that may be involved in the complex interaction between host and virus. Resident brain cells appeared to be the source of early immune mediators while infiltrating leukocyte are playing important role in the severity of the disease. This will aid further attempts to control the inflammatory conditions during JEV infection. The further elucidation of significantly regulated receptor-ligand interaction and resulted signal transduction processes may demonstrate the complexity of the interplay between the virus and the host, and may open new ways for therapeutic strategies for diseases which has inflammation as the major cause of disease severity.

Materials and methods
=====================

Virus
-----

The JaOArS982 strain of Japanese encephalitis virus was employed throughout this study. The virus was propagated in suckling BALB/c mice. The brain tissue was harvested when clinical signs of sickness became apparent. A 10% suspension of the brain tissue was made by homogenization in the minimum essential medium (MEM). It was then centrifuged at 10,000 × g to remove cellular debris and filtered through 0.22 μm sterile filters. The mouse brain tissue-derived virus was stored at -70°C in small aliquots and was used as the source of virus for all the experiments.

Virus Titration
---------------

The infectivity of the virus stock (PFU JEV/ml) was assessed by a quantitative plaque-forming assay on the monolayers of porcine stable (PS) kidney cells. Monolayers of cells were inoculated with 10-fold dilutions of virus sample made in MEM containing 1% FBS and incubated for 1 h at 37°C with occasional shaking. The inoculum was removed by aspiration and the monolayers were further overlaid with 1.25% methylcellulose containing MEM with 1% FBS. After incubation for 4 days the overlay medium was removed, the cells were fixed with methanol and stained with 0.5% crystal violet, and the end-point titre was determined by macroscopic counting of plaques.

Virus infection
---------------

We have adopted a new mice animal model for Japanese encephalitis virus infection with modification in age and the route of infection, as reported by us earlier \[[@B8]\]. Briefly, one-week-old BALB/c mice of either sex were injected subcutaneously with approximately 10^3^PFU (in 50 μl of PBS) of JEV. Control animals received the same volume of PBS as the experimental group. All experiments were performed according to the protocol approved by the Institutional Animal Ethics Committee.

Viral load in the CNS of infected mice
--------------------------------------

Mice were sacrificed each day post-infection (DPI) from day 1 to day 6 to harvest brain tissue. The animals were perfused with cold PBS before harvesting the brain tissue. The cerebral cortex of brain tissue was homogenized in the minimum essential medium (MEM). It was then centrifuged at 10,000 × g and filtered through 0.22 μm sterile filters. Presence and growth kinetics of virus was confirmed and titrated in the prepared sample by plaque formation on the monolayers of porcine stable (PS) kidney cells.

Histopathological Analysis
--------------------------

Mock- and JEV-infected animals were sacrificed after specific time points. Tissue sample of brain was dissected out and fixed in Bouin\'s solution. After fixation, small pieces were processed by automated tissue processor (Leica TP1020) dehydrated and embedded in paraffin wax. Multiple sections of 12-μm thickness were prepared using automatic microtome (Microm HM360) and stained with hematoxylin and eosin in Leica Autostain-XL. Microscopic observation was performed on sections of cerebral cortex under LEICA DMLB microscope and photographs were taken using Leica DC 500 camera.

Sample Acquisition, RNA Isolation and Quality Control
-----------------------------------------------------

Brain tissues were collected from mock- and JEV-infected group of three mice at different days post infection. The sections of cerebral cortex of brain tissue were stored in RNA *later*(Qiagen, Hilden, Germany) at -70°C until processed for RNA extraction. Total RNA was extracted using the Qiagen (GmbH, Hilden) RNAEasy Mini kit according to the instructions of the manufacturer. RNA quality and integrity was assessed using RNA 6000 Nano Lab Chip on the 2100 Bioanalyzer (Agilent, Germany) following the manufacturer\'s protocol. RNA samples with RIN (RNA Integrity Number) ≥ 8 were used in all experiments. Equal concentration of total RNA from three animals of each mock- and JEV-infected group were pooled and used for microarray analysis. Validation of microarray data of relevant genes was carried out by qRT-PCR with three biological replicates without pooling of RNA.

Microarrays and Hybridization
-----------------------------

Low RNA Input Fluorescent Linear Amplification Kit (Agilent, Santa Clara, CA) was used for labeling. Briefly, both first and second strand cDNA were synthesized by incubating 500 ng of pooled total RNA with 1.2 μl of oligo dT-T7 promoter primer in nuclease-free water at 65°C for 10 min followed by incubation with 4.0 μl of 5× First strand buffer, 2 μl of 0.1 M DTT, 1 μl of 10 mM dNTP mix, 1 μl of 200 U/μl MMLV-RT, and 0.5 μl of 40 U/μl RNaseOUT, at 40 °C for 2 h. Immediately following cDNA synthesis, the reaction mixture was incubated with 2.4 μl of 10 mM Cyanine-3-CTP or 2.4 μl of 10 mM Cyanine-5-CTP (Perkin-Elmer, Boston, MA), 20 μl of 4× Transcription buffer, 8 μl of NTP mixture, 6 μl of 0.1 M DTT, 0.5 μl of RNaseOUT, 0.6 μl of inorganic pyrophosphatase, 0.8 μl of T7 RNA polymerase, and 15.3 μl of nuclease-free water at 40 °C for 2 h. Qiagen\'s RNeasy mini spin columns were used for purifying amplified cRNA samples. The quantity and specific activity of cRNA was determined by using NanoDrop ND-1000 UV-VIS Spectrophotometer version 3.2.1. Samples with specific activity \>8 were used for hybridization. 825 ng of each Cyanine 3 or Cyanine 5 labeled cRNA in a volume of 41.8 μl were combined with 11 μl of 10× Blocking agent and 2.2 μl of 25× Fragmentation buffer (Agilent), and incubated at 60°C for 30 minutes in dark. The fragmented cRNA were mixed with 55 μl of 2× hybridization buffer (Agilent). About 110 μl of the resulting mixture was applied to the Agilent Whole Genome Mouse 4 × 44 k Gene Expression Microarray (AMADID: 14868, Agilent Technologies) and hybridized in a two-color comparative format at 65°C for 17 h in an Agilent Microarray Hybridization Chamber (SureHyb: G2534A) with hybridization oven. After hybridization, slides were washed with Agilent Gene expression wash buffer I for 1 min at room temperature followed by a 1 min wash with Agilent gene expression wash buffer II for 37°C. Slides were finally rinsed with acetonitrile for cleaning up and drying. Hybridized arrays were scanned at 5 μm resolution on an Agilent DNA Microarray Scanner, Model G2565BA. Data extraction from images was done using Feature Extraction software of Agilent.

Microarray Data Analysis
------------------------

Feature extracted data was analyzed using GeneSpring Gx v 11.0 software from Agilent. Normalization of the data was done using per spot per chip intensity dependent lowess normalization. Further quality control of normalized data was done using correlation based condition tree to eliminate experimental error. Genes that had ≥2 (Up regulated) and ≤-2 (Down regulated) fold change at 5 DPI were filtered from the data, irrespective of their regulation at early time points and selected for further analysis. Differentially regulated genes were clustered using gene tree to identify significant gene expression patterns. Ontology based biological analysis was done using Gene Ontology browser in GeneSpring Gx.

Real Time qRT-PCR
-----------------

The quantitative real-time RT-PCR was carried out to validate the microarray data with three biological replicates without pooling of RNA, using gene-specific primers from Quanti Tect primer assay kit (Qiagen Germany). Quanti Fast one-step RT-PCR kit (Qiagen Germany) was used for real time PCR and Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as an endogenous reference gene \[[@B8]\]. The relative quantification level of expression was determined using the 2^nd^derivative maximum analysis with the determination of the crossing points for each transcript. Crossing point values for each gene was normalized to the respective crossing point values for the reference gene Gapdh. Data are presented as normalized ratios of genes along with standard error using the Roche Applied Science E-method \[[@B48]\].

Statistical analysis
--------------------

For microarray, sequential Student\'s *t*test (time point versus mock) was used to identify genes differentially expressed (*P*≤ 0.05) for each group and the experiment was repeated once. The quantitative real-time RT-PCR data was analyzed by one-way ANOVA followed by Dunnet\'s test for comparison between mock- and JEV-infected groups. The level of significance was set at *P*≤ 0.05. The data were expressed as mean ± SE of three animals per group. The real-time RT-PCR experiments were repeated twice.
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###### Additional file 1

**Figure S1. Histopathology of the brain of JEV infected mouse**. Hematoxylin/eosin-stained section of cerebral cortex of mice at different days post infection with subcutaneously infected JEV. (a) Control mouse brain showing normal arrangement of neurons in various layers with blood vessels and glial cells (b) Brain section showing congestion and dilation of blood vessel (thick black arrow) at 1 DPI (c) Brain section showing moderate dilation of blood vessel (thick black arrow) at 2 DPI (d) Brain section showing leukocyte infiltration (thin black arrow) at 4 DPI (e) Brain section showing perivascular cuffing (thick black arrow) accumulating leukocytes (thin black arrow) and neurodegenration at 5 DPI (f) Showing enlarged view of perivascular cuffing and leukocyte transmigration. (Scale bar = 50 μM).
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###### Additional file 2

**Table S1. Genes up regulated in mouse brain after infection with Japanese encephalitis virus, classified as being involved in immune response**. Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.
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###### Additional file 3

**Table S2. Genes up regulated in mouse brain after infection with Japanese encephalitis virus, classified as being involved in inflammation**. Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.
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###### Additional file 4

**Table S3. Genes up regulated in mouse brain after infection with Japanese encephalitis virus, classified as being involved in defense response**. Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.
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###### Additional file 5

**Table S4. Genes up regulated in mouse brain after infection with Japanese encephalitis virus that can be involved in Interferon response**. Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.
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###### Additional file 6

**Table S5. Genes up regulated in mouse brain after infection with Japanese encephalitis virus that can be classified as being involved in Proteolysis**. Genes were considered significantly upregulated or downregulated if the change in their relative expression levels was ≥ 2 fold or ≤ -2 fold, respectively.
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